Use of recombinant human erythropoietin and risk of severe retinopathy in extremely low-birth-weight infants

Pharmacotherapy

Volumn 28, Issue 11 PART 1, 2008, Pages 1335-1340

  Schneider, Jacqueline K ^a   Gardner, Debra K ^b   Cordero, Leandro ^c  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Anemia of prematurity; ELBW; Extremely low birth weight infants; Recombinant human erythropoietin; Retinopathy of prematurity; rHuEPO; ROP

Indexed keywords

IRON; RECOMBINANT ERYTHROPOIETIN;

ABSENCE OF SIDE EFFECTS; ANEMIA; ARTICLE; BIRTH WEIGHT; BLOOD TRANSFUSION; CONTROL GROUP; CONTROLLED STUDY; DISEASE SEVERITY; ENTERIC FEEDING; FEMALE; GESTATIONAL AGE; HOSPITALIZATION; HUMAN; INFANT; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; NEWBORN INTENSIVE CARE; OPHTHALMOLOGY; PREMATURITY; RETROLENTAL FIBROPLASIA; RETROSPECTIVE STUDY; RISK FACTOR; TOTAL PARENTERAL NUTRITION; TREATMENT DURATION; UNIVERSITY HOSPITAL; VITAMIN SUPPLEMENTATION;

ANEMIA, NEONATAL; BIRTH WEIGHT; BLOOD TRANSFUSION; COHORT STUDIES; ERYTHROPOIETIN, RECOMBINANT; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; MALE; PREGNANCY; PREGNANCY OUTCOME; RETINOPATHY OF PREMATURITY; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 55549114011     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.28.11.1335     Document Type: Article

References (20)

1. Shannon KM. Anemia of prematurity: progress and prospects. Am J Pediatr Hematol Oncol 1990;12:14-20.
2. Shannon KM, Mentzer WC, Abels RI, et al. Enhancement of erythropoiesis by recombinant human erythropoietin in low birth weight infants: a pilot study. J Pediatr 1992;120:586-92.
3. Ohls RK, Harcum J, Schibler KR, Christensen RD. The effect of erythropoietin on the transfusion requirements of preterm infants weighing 750 grams or less: a randomized, double-blind, placebo-controlled study. J Pediatr 1997;131:661-5.
4. Donate H, Vain N, Rendo P, et al. Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo-controlled, multicenter trial. Pediatrics 2000;105:1066-72.
5. Yeo CL, Choo S, Ho L. Effect of recombinant human erythropoietin on transfusion needs in preterm infants. J Paediatr Child Health 2001;37:352-8.
6. Ohls RK. Human recombinant erythropoietin in the prevention and treatment of anemia of prematurity. Paediatr Drugs 2002;4:111-21.
7. Ohlsson A, Aher SM. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2006;(3):CD004863.
8. American Academy of Pediatrics Section on Ophthalmology, American Academy of Ophthalmology, American Association for Pediatric Ophthalmology and Strabismus. Screening examination of premature infants for retinopathy of prematurity. Pediatrics 2006:117:572-6.
9. Committee for the Classification of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. Arch Opthalmol 1984;102:1130-4.
10. Good WV, Hardy RJ, Dobson V, et al. The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study. Pediatrics 2005;116:15-23.
11. Watanabe D, Suzuma K, Matsui S, et al. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. N Engl J Med 2005;353:782-93.
12. Aher S, Ohlsson A. Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2006;(3):CD004868.
13. Romagnoli C, Zecca E, Gallini F, Girlando P, Zuppa AA. Do recombinant human erythropoietin and iron supplementation increase the risk of retinopathy of prematurity? Eur J Pediatr 2000;159:627-34.
14. Groh-Wargo S. Recommended enteral nutrient intakes. In: Groh-Wargo S, Thompson M, Cox JH, Hartline JV, eds. Nutritional care for high-risk newborns. Chicago, IL: Precept Press Inc., 2000:243.
15. Hesse L, Eberl W, Schlaud M, Poets CF. Blood transfusion: iron load and retinopathy of prematurity. Eur J Pediatr 1997;156:465-70.
16. Saugstad OD. Oxidative stress in the newborn: a 30-year perspective. Biol Neonate 2005;88:228-36.
17. Maier RF, Obladen M, Scigalla P, et al. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. N Engl J Med 1994;330:1173-8.
18. Ohls RK, Ehrenkranz RA, Wright LL, et al. Effects of early erythropoietin therapy on the transfusion requirements of preterm infants below 1250 grams birth weight: a multicenter, ramdomized, controlled trial. Pediatrics 2001;108:934-42.
19. Maier RF, Obladen M, Muller-Hansen I, et al. Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g. J Pediatr 2002;141:8-15.
20. Haiden N, Cardona F, Schwindt J, et al. Changes in thrombopoiesis and platelet reactivity in extremely low birth weight infants undergoing erythropoietin therapy for treatment of anaemia of prematurity. Thromb Haemost 2005;93:118-23.